Follow
Habib Zarredar
Habib Zarredar
Tabriz medical science
Verified email at tbzmed.ac.ir
Title
Cited by
Cited by
Year
Potential of microalgae and lactobacilli in biosynthesis of silver nanoparticles
M Mohseniazar, M Barin, H Zarredar, S Alizadeh, D Shanehbandi
BioImpacts: BI 1 (3), 149, 2011
1332011
Overview of CD24 as a new molecular marker in ovarian cancer
V Tarhriz, M Bandehpour, S Dastmalchi, E Ouladsahebmadarek, ...
Journal of cellular physiology 234 (3), 2134-2142, 2019
1012019
Antibody based EpCAM targeted therapy of cancer, review and update
S Eyvazi, S Farajnia, S Dastmalchi, F Kanipour, H Zarredar, ...
Current Cancer Drug Targets 18 (9), 857-868, 2018
922018
Development of novel carboxymethyl cellulose/k-carrageenan blends as an enteric delivery vehicle for probiotic bacteria
A Dafe, H Etemadi, H Zarredar, GR Mahdavinia
International journal of biological macromolecules 97, 299-307, 2017
852017
CRISPR and personalized Treg therapy: new insights into the treatment of rheumatoid arthritis
F Safari, S Farajnia, M Arya, H Zarredar, A Nasrolahi
Immunopharmacology and immunotoxicology 40 (3), 201-211, 2018
572018
Rosa canina L. fruit hydro-alcoholic extract effects on some immunological and biochemical parameters in rats
S Sadigh-Eteghad, H Tayefi-Nasrabadi, Z Aghdam, H Zarredar, ...
BioImpacts: BI 1 (4), 219, 2011
492011
Occurrence of methicillin resistant and enterotoxigenic Staphylococcus aureus in traditional cheeses in the north west of Iran
D Shanehbandi, B Baradaran, S Sadigh-Eteghad, H Zarredar
International Scholarly Research Notices 2014, 2014
402014
Long non‐coding RNAs as potential biomarkers in the prognosis and diagnosis of lung cancer: A review and target analysis
Y Aftabi, K Ansarin, D Shanehbandi, M Khalili, E Seyedrezazadeh, ...
IUBMB life 73 (2), 307-327, 2021
372021
Critical Micrornas in Lung Cancer: Recent Advances and Potential Applications.
SF Zarredar H , Ansarin K , Baradaran B , Shekari N , Eyvazi S
Anti-cancer Agents in Medicinal Chemistry, 2018
36*2018
Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro
H Zarredar, S Pashapour, K Ansarin, M Khalili, R Baghban, S Farajnia
Journal of Cellular Physiology, 2018
282018
Micronutrient therapy and effective immune response: a promising approach for management of COVID-19
F Lotfi, M Akbarzadeh-Khiavi, Z Lotfi, L Rahbarnia, A Safary, H Zarredar, ...
Infection 49 (6), 1133-1147, 2021
242021
Potential molecular targets in the treatment of lung cancer using siRNA technology
H Zarredar, K Ansarin, B Baradaran, S Ahdi Khosroshahi, S Farajnia
Cancer investigation 36 (1), 37-58, 2018
242018
Synergistic effect of novel EGFR inhibitor AZD8931 and p38α siRNA in lung adenocarcinoma cancer cells
H Zarredar, S Farajnia, K Ansarin, B Baradaran, M Aria, M Asadi
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2019
222019
Anticancer Impacts of Terminalia catappa Extract on SW480 Colorectal Neoplasm Cell Line
D Shanehbandi, H Zarredar, M Asadi, V Zafari, S Esmaeili, ...
Journal of Gastrointestinal Cancer 52, 99-105, 2021
202021
Targeting the KRAS, p38α, and NF‐κB in lung adenocarcinoma cancer cells: The effect of combining RNA interferences with a chemical inhibitor
H Zarredar, S Pashapour, S Farajnia, K Ansarin, B Baradaran, ...
Journal of Cellular Biochemistry 120 (6), 10670-10677, 2019
202019
The search for a promising cell factory system for production of edible vaccine: Spirulina as a robust alternate to plants
A Barzegari, N Saeedi, H Zarredar, J Barar, Y Omidi
Human Vaccines & Immunotherapeutics 10 (8), 2497-2502, 2014
182014
Vibration and glycerol-mediated plasmid DNA transformation for Escherichia coli
D Shanehbandi, AA Saei, H Zarredar, A Barzegari
FEMS microbiology letters 348 (1), 74-78, 2013
172013
Design and in silico evaluation of a novel cyclic disulfide-rich anti-VEGF peptide as a potential antiangiogenic drug
R Baghban, S Ghasemali, S Farajnia, R Hoseinpoor, S Andarzi, ...
International Journal of Peptide Research and Therapeutics 27, 2245-2256, 2021
112021
Caspase-7 deficiency in Chinese hamster ovary cells reduces cell proliferation and viability
F Safari, S Farajnia, AB Behbahani, H Zarredar, M Barekati-Mowahed, ...
Biological Research 53, 2020
112020
CRISPR‐Cas system: Toward a more efficient technology for genome editing and beyond
V Ahmadzadeh, S Farajnia, R Baghban, L Rahbarnia, H Zarredar
Journal of Cellular Biochemistry 120 (10), 16379-16392, 2019
102019
The system can't perform the operation now. Try again later.
Articles 1–20